Oncoinvent develops new radiopharmaceutical products for better treatment options for cancer patients.
Oncoinvent AS designs and develops cancer treatments by applying known physical and chemical principles of selected novel materials in new ways in order to maximize their medical benefit while minimizing potential safety concerns.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 29, 2021 | Series Unknown | kr250M | 2 | — | — | Detail |
May 19, 2020 | Series Unknown | $6M | 4 | — | — | Detail |
Feb 9, 2017 | Series Unknown | $25M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Geveran Trading | — | Series Unknown |
MP Pensjon | — | Series Unknown |
CGS Holding | — | Series Unknown |
Alpine Capital AS | — | Series Unknown |
Helene Sundt | — | Series Unknown |
Sciencons | — | Series Unknown |